| Literature DB >> 31519947 |
Moo-Nyun Jin1, Pil-Sung Yang2, Changho Song1, Hee Tae Yu1, Tae-Hoon Kim1, Jae-Sun Uhm1, Jung-Hoon Sung2, Hui-Nam Pak1, Moon-Hyoung Lee1, Boyoung Joung3.
Abstract
Although exercise prevents cardiovascular disease and mortality, vigorous exercise and endurance athletics can cause atrial fibrillation (AF). However, no large cohort study has assessed the relationship between physical activity and AF in the general population. We assessed the effect of physical activity at different energy expenditures on the incidence of AF. We studied 501,690 individuals without pre-existing AF (mean age, 47.6 ± 14.3 years; 250,664 women [50.0%]) included in the Korean National Health Insurance Service database. The physical activity level was assessed using a standardized self-reported questionnaire at baseline. During a median follow-up of 4 years, 3,443 participants (1,432 women [41.6%]) developed AF. The overall incidence of AF at follow-up was 1.79 per 1,000 person-years. The subjects who met the recommended physical activity level (500-1,000 metabolic equivalent task [MET] minutes/week) had a 12% decreased AF risk (adjusted hazard ratio [HR]: 0.88, 95% confidence interval [CI]: 0.80-0.97), but not the insufficiently (1-500 MET-minutes/week; HR: 0.94, 95% CI: 0.86-1.03) and highly active subjects (≥1,000 MET-minutes/week; HR: 0.93, 95% CI: 0.85-1.03). The recommended minimum key target range of physical activity level was associated with the maximum benefit for reduced AF risk in the general population. The dose-response relationship between physical activity level and AF risk showed a U-shaped pattern. Although exceeding the key target range attenuated this benefit, it did not increase the AF risk beyond that during inactivity.Entities:
Mesh:
Year: 2019 PMID: 31519947 PMCID: PMC6744571 DOI: 10.1038/s41598-019-49686-w
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Baseline characteristics stratified by the leisure-time physical activity level.
| Characteristic | ALL | Physical activity level, MET min/week | ||||
|---|---|---|---|---|---|---|
| None | 1 to <500 | 500 to <1000 | ≥1000 | P for trend | ||
| Participants | 501,690 | 125,259 (25.0%) | 157,515 (31.4%) | 132,823 (26.5%) | 86,093 (17.2%) | |
| Age | 47.6 ± 14.3 | 50.4 ± 14.6 | 45.7 ± 13.9 | 46.5 ± 14.3 | 48.7 ± 13.9 | <0.001 |
| Female | 250,664 (50.0%) | 69,307 (55.3%) | 81,601 (51.8%) | 62,427(47.0%) | 15,537 (42.6%) | <0.001 |
| BMI (kg/m2) | 23.7 ± 3.3 | 23.7 ± 3.4 | 23.5 ± 3.4 | 23.7 ± 3.3 | 24.0 ± 3.1 | <0.001 |
| Waist circumflex | 80.0 ± 9.4 | 80.2 ± 9.5 | 79.6 ± 9.5 | 80.0 ± 9.3 | 80.6 ± 8.9 | <0.001 |
| Heart failure | 10,937 (2.2%) | 3,798 (3.0%) | 2,883 (1.8%) | 2,458 (1.9%) | 1,798 (2.1%) | <0.001 |
| Hypertension | 107,925 (21.5%) | 31,072 (24.8%) | 29,056 (18.4%) | 26,872 (20.2%) | 20,925 (24.3%) | 0.001 |
| Diabetes | 31,396 (6.3%) | 8,590 (6.9%) | 8,129 (5.2%) | 8,037 (6.1%) | 6,640 (7.7%) | <0.001 |
| Previous MI | 4,555 (0.9%) | 1,416 (1.1%) | 1,177 (0.7%) | 1,104 (0.8%) | 858 (1.0%) | 0.001 |
| History of stroke/TIA | 18,461 (3.7%) | 5,986 (4.8%) | 4,821 (3.1%) | 4,404 (3.3%) | 3,250 (3.8%) | <0.001 |
| Chronic kidney disease | 29,265 (5.8%) | 8,496 (6.8%) | 8,104 (5.1%) | 7,470 (5.6%) | 5,195 (6.0%) | <0.001 |
| Dyslipidemia | 143,497 (28.6%) | 38,329 (31.0%) | 42,371 (26.9%) | 36,659 (27.6%) | 26,138 (30.4%) | <0.001 |
| COPD | 11,453 (2.3%) | 3,841 (3.1%) | 3,074 (2.0%) | 2,639 (2.0%) | 1,899 (2.2%) | <0.001 |
| Cancer | 33,396 (6.7%) | 9,065 (7.2%) | 9,331 (5.9%) | 8,421 (6.3%) | 6,579 (7.6%) | 0.003 |
| Smoker (Ex or current) | 188,985 (37.7%) | 40,409 (32.3%) | 58,690 (37.3%) | 54,192 (40.8%) | 35,694 (41.5%) | <0.001 |
| Alcohol drinker ( ≥ 1time/week) | 236,772 (47.2%) | 45,669 (36.5%) | 77,592 (49.3%) | 69,121 (52.0%) | 44,390 (51.6%) | <0.001 |
| Systolic BP (mmHg) | 122.3 ± 15.3 | 123.0 ± 15.9 | 121.3 ± 15.1 | 122.1 ± 15.1 | 123.1 ± 15.0 | <0.001 |
| Diastolic BP (mmHg) | 76.1 ± 10.2 | 76.4 ± 10.4 | 75.7 ± 10.2 | 76.0 ± 10.1 | 76.5 ± 10.1 | <0.001 |
| Fasting glucose (mg/dl) | 97.9 ± 24.8 | 98.9 ± 26.7 | 96.9 ± 23.5 | 97.5 ± 24.2 | 98.7 ± 25.1 | <0.001 |
| Total cholesterol (mg/dl) | 194.9 ± 37.3 | 196.1 ± 38.1 | 194.7 ± 37.1 | 194.3 ± 36.9 | 194.7 ± 37.1 | <0.001 |
| Triglyceride | 132.0 ± 93.9 | 136.0 ± 95.5 | 131.8 ± 93.6 | 130.7 ± 94.1 | 128.9 ± 91.5 | <0.001 |
| LDL (mg/dl) | 113.7 ± 37.2 | 114.7 ± 38.9 | 113.4 ± 36.5 | 113.1 ± 36.6 | 113.6 ± 37.0 | <0.001 |
| HDL (mg/dl) | 56.4 ± 27.2 | 56.7 ± 33.5 | 56.2 ± 25.3 | 56.3 ± 24.7 | 56.5 ± 24.0 | <0.001 |
Values are expressed as n (%) or means ± standard deviations.
BMI: body mass index, BP: blood pressure, COPD: chronic obstructive pulmonary disease, HDL: high-density lipoprotein, LDL: low-density lipoprotein, MET: metabolic equivalent task, MI: myocardial infarction, TIA: transient ischemic attack.
Risk of atrial fibrillation in relation to the total leisure-time physical activity.
| Physical activity level, MET min/week | ||||
|---|---|---|---|---|
| None | 1 to <500 | 500 to <1000 | ≥1000 | |
| Incidence (%) | 1,084 (0.87%) | 925 (0.59%) | 796 (0.60%) | 638 (0.74%) |
| Incidence (/1000 person-years) | 2.27 | 1.52 | 1.56 | 1.91 |
| Hazard ratio (95% confidence interval), | ||||
| Age and sex adjusted | 1.00 (ref.) | 0.94 (0.86–1.02) | 0.88 (0.80–0.96) | 0.94 (0.85–1.04) |
| P value | 0.145 | 0.005 | 0.211 | |
| Fully adjusted† | 1.00 (ref.) | 0.94 (0.86–1.03) | 0.88 (0.80–0.97) | 0.93 (0.85–1.03) |
| P value | 0.165 | 0.007 | 0.172 | |
†The model was adjusted for age, sex, body mass index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke or transient ischemic attack, chronic kidney disease, smoking, and alcohol drinking.
MET: metabolic equivalent task.
Figure 1Multivariable adjusted relative risk of atrial fibrillation according to physical activity level as classified in the Physical Activity Guidelines. †Minimum key guidelines target range in Physical Activity Guidelines for Americans by the U.S. Department of Health and Human Services (2018): Doing the equivalent of 500 to 1,000 MET-minutes a week of physical activity. ‡Multivariable adjusted hazard ratio (HR): age, sex, BMI, HF, HTN, DM, Previous MI, Stroke or TIA, CKD, Smoking, and Alcohol.
Risk of atrial fibrillation according to the intensity of physical activity.
| Hazard ratio | Physical activity level, MET min/week | |||
|---|---|---|---|---|
| None | 1 to <500 | 500 to <1000 | ≥1000 | |
| Moderate | ||||
| Age and gender adjusted | 1.00 (ref.) | 0.96 (0.89–1.05) | 0.89 (0.82–0.98) | 0.88 (0.76–1.02) |
| P value | 0.383 | 0.014 | 0.095 | |
| Fully adjusted† | 1.00 (ref.) | 0.96 (0.89–1.05) | 0.90 (0.82–0.98) | 0.88 (0.76–1.02) |
| P value | 0.393 | 0.018 | 0.082 | |
| Vigorous | ||||
| Age and gender adjusted | 1.00 (ref.) | 0.98 (0.89–1.07) | 1.06 (0.93–1.21) | 1.08 (0.93–1.25) |
| P value | 0.629 | 0.359 | 0.334 | |
| Fully adjusted† | 1.00 (ref.) | 0.99 (0.90–1.08) | 1.05 (0.93–1.20) | 1.07 (0.92–1.23) |
| P value | 0.754 | 0.434 | 0.400 | |
†The model was adjusted for age, sex, body mass index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke or transient ischemic attack, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for both moderate- and vigorous-intensity activities.
MET: metabolic equivalent task.
Figure 2Joint association of moderate-intensity and vigorous-intensity physical activities with the adjusted relative risk of atrial fibrillation. †The multivariable adjusted hazard ratio was adjusted for age, sex, body mass index, heart failure, hypertension, diabetes, previous myocardial infarction, prior stroke or transient ischemic attack, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for both moderate- and vigorous-intensity activities.
Association between increasing physical activity level and risk of atrial fibrillation according to subgroups.
| Characteristic | Fully adjusted hazard ratio† (95% confidence interval) | ||||
|---|---|---|---|---|---|
| Physical activity level, MET*min/week | |||||
| None | 1 to <500 | 500 to <1000 | ≥1000 | P for interaction | |
| Age | 0.210 | ||||
| <50 | 1.00 (ref.) | 0.93 (0.74–1.17) | 0.81 (0.63–1.04) | 0.81 (0.61–1.08) | |
| 50 to 64 | 1.00 (ref.) | 0.98 (0.84–1.15) | 0.94 (0.80–1.11) | 1.05 (0.89–1.23) | |
| ≥65 | 1.00 (ref.) | 0.92 (0.82–1.04) | 0.85 (0.78–0.97) | 0.85 (0.74–0.98) | |
| Sex | 0.223 | ||||
| Male | 1.00 (ref.) | 0.92 (0.81–1.03) | 0.92 (0.81–1.03) | 0.96 (0.85–1.09) | |
| Female | 1.00 (ref.) | 0.97 (0.85–1.10) | 0.83 (0.72–0.96) | 0.89 (0.75–1.05) | |
| BMI | 0.084 | ||||
| <25 | 1.00 (ref.) | 0.99 (0.88–1.11) | 0.88 (0.78–0.99) | 0.89 (0.78–1.02) | |
| ≥25 | 1.00 (ref.) | 0.88 (0.77–1.02) | 0.90 (0.78–1.04) | 1.02 (0.88–1.19) | |
| Central obesity by waist | 0.033 | ||||
| Yes | 1.00 (ref.) | 0.95 (0.83–1.08) | 0.87 (0.76–1.003) | 1.05 (0.90–1.22) | |
| No | 1.00 (ref.) | 0.94 (0.83–1.06) | 0.89 (0.79–1.008) | 0.87 (0.76–0.99) | |
| Heart failure | 0.622 | ||||
| Yes | 1.00 (ref.) | 1.01 (0.79–1.28) | 0.88 (0.67–1.15) | 0.95 (0.71–1.27) | |
| No | 1.00 (ref.) | 0.93 (0.85–1.02) | 0.88 (0.80–0.97) | 0.92 (0.83–1.03) | |
| Hypertension | 0.193 | ||||
| Yes | 1.00 (ref.) | 0.94 (0.84–1.06) | 0.85 (0.75–0.96) | 0.87 (0.76–0.99) | |
| No | 0.95 (0.82–1.09) | 0.93 (0.80–1.07) | 1.00 (0.86–1.17) | ||
| High BP (>130/80 mmHg) | 0.028 | ||||
| Yes | 1.00 (ref.) | 0.98 (0.88–1.10) | 0.93 (0.83–1.05) | 1.01 (0.89–1.14) | |
| No | 1.00 (ref.) | 0.87 (0.75–1.01) | 0.80 (0.68–0.93) | 0.81 (0.69–0.96) | |
| Diabetes | 0.857 | ||||
| Yes | 1.00 (ref.) | 1.03 (0.83–1.28) | 0.87 (0.69–1.09) | 0.92 (0.73–1.17) | |
| No | 1.00 (ref.) | 0.92 (0.84–1.02) | 0.88 (0.80–0.98) | 0.93 (0.84–1.04) | |
| Chronic kidney disease | 0.856 | ||||
| Yes | 1.00 (ref.) | 1.05 (0.86–1.28) | 0.83 (0.66–1.04) | 0.98 (0.77–1.25) | |
| No | 1.00 (ref.) | 0.92 (0.83–1.01) | 0.89 (0.80–0.98) | 0.92 (0.82–1.02) | |
| Previous MI | 0.795 | ||||
| Yes | 1.00 (ref.) | 0.98 (0.63–1.53) | 0.67 (0.40–1.12) | 0.93 (0.57–1.54) | |
| No | 1.00 (ref.) | 0.94 (0.86–1.03) | 0.89 (0.81–0.98) | 0.93 (0.84–1.03) | |
| Dyslipidemia | 0.752 | ||||
| Yes | 1.00 (ref.) | 0.93 (0.81–1.05) | 0.86 (0.75–0.98) | 0.94 (0.81–1.08) | |
| No | 1.00 (ref.) | 0.96 (0.85–1.08) | 0.91 (0.80–1.03) | 0.93 (0.81–1.06) | |
| CHDSV score‡ | |||||
| 0 | 1.00 (ref.) | 0.96 (0.82–1.11) | 0.95 (0.81–1.11) | 1.0 (0.84–1.18) | 0.216 |
| ≥1 | 1.00 (ref.) | 0.94 (0.84–1.05) | 0.84 (0.75–0.95) | 0.88 (0.78–1.00) | |
| 1~2 | 1.00 (ref.) | 0.94 (0.83–1.07) | 0.84 (0.74–0.96) | 0.89 (0.77–1.02) | |
| ≥3 | 1.00 (ref.) | 0.93 (0.73–1.19) | 0.84 (0.65–1.09) | 0.85 (0.63–1.13) | |
| Alcohol (≥1time/week) | 0.078 | ||||
| Drinker | 1.00 (ref.) | 0.94 (0.80–1.10) | 0.95 (0.81–1.11) | 1.03 (0.87–1.21) | |
| Non-drinker | 1.00 (ref.) | 0.95 (0.85–1.06) | 0.85 (0.76–0.95) | 0.87 (0.76–0.99) | |
| Smoking (former + current) | 0.888 | ||||
| Smoker | 1.00 (ref.) | 0.99 (0.85–1.15) | 0.91 (0.79–1.06) | 0.93 (0.79–1.09) | |
| Never | 1.00 (ref.) | 0.91 (0.82–1.02) | 0.86 (0.77–0.97) | 0.94 (0.83–1.07) | |
†The model was adjusted for age, sex, BMI, heart failure, hypertension, diabetes, previous MI, prior stroke or TIA, chronic kidney disease, smoking, and alcohol drinking and mutually adjusted for both moderate- and vigorous-intensity activities.
‡CHDSV score assigns 1 point for heart failure, hypertension, diabetes, prior stroke or TIA, and vascular disease.
BMI: body mass index, BP: blood pressure, MET: metabolic equivalent task, MI: myocardial infarction, TIA: transient ischemic attack.